The radiation and medical technology group Eckert & Ziegler has secured a major order from the USA. The order is for the delivery of carrier-free lutetium-177 to the US company Point Biopharma, the.
EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Contract/AllianceEckert & Ziegler collaborates with RefleXion Medical and Telix Pharmaceuticals to Expand Treatment Options for Prostate Cancer Patients 13.09.2023 / 15:00 CET/CESTThe issuer is solely responsible for the content of this an.
Meeting rising demands of a new radiotheranostic era europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.
Enrollment in PNT2002 s SPLASH trial is complete and topline data is expected in the fourth quarter of 2023 Next-generation actinium-225 PSMA program PNT2001 phase 1 trial design released; first. -Today at 07:31 am- MarketScreener